Accumulation of amyloid β and tau in Alzheimer’s disease was found to impair the glutamatergic and GABAergic systems, which are the main excitatory and inhibitory systems in the brain. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.